MAIA Biotechnology, Inc. Shareholders' Equity
MAIA Biotechnology, Inc. (MAIA) had Shareholders' Equity of $20.68 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $20.68M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $27.76M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.38M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $41.67K.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $20.68M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $27.76M 10-Q · filed 2026-08-10 |
| 2025-12-31 | $2.38M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $41.67K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $3.88M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $4.94M 10-Q · filed 2026-08-10 |
| 2024-12-31 | $3.63M 10-Q · filed 2026-08-10 |
| 2024-09-30 | $1.62M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $3.16M 10-Q · filed 2025-11-07 |
| 2024-03-31 | -$5.76M 10-Q · filed 2025-11-07 |
| 2023-12-31 | $477.51K 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |